| Old Articles: <Older 601-610 Newer> |
|---|
 |
HBS Working Knowledge
December 23, 2013
Michael Blanding |
Just How Independent are `Independent' Directors? A rule in China, which mandates publicly-traded company directors to explain their dissenting votes, provides Tarun Khanna and Juan Ma with rich data looking into the inner workings of how board members interact.   |
Chemistry World
December 20, 2013
Patrick Walter |
Chinese police seize 222m pounds of fake drugs Counterfeit medicines and raw materials worth more than Yuan2.2 billion have been seized by Chinese authorities. |
Fast Company
Dec 2013/Jan 2014
Adam Minter |
Your iPhone's After Life The author's adventures in recycling old phones in China. |
Chemistry World
November 14, 2013
Hepeng Jia |
Carbon trading schemes debut in China After years of cautious planning, pilot carbon exchanges are being set up across China. However, experts are warning that such trading schemes face a number of challenges in the world's largest carbon dioxide emitter. |
On Wall Street
September 1, 2013
Milton Ezrati |
Can China's Economy Make a Soft Landing Predictions of a hard landing for this nation's economy are overblown. |
Chemistry World
August 29, 2013
Emma Stoye |
Couple charged in GSK corruption investigation A UK consultant and his American wife have been charged in relation to the corruption investigation at GlaxoSmithKline in China. |
Chemistry World
August 28, 2013
Hepeng Jia |
China to spend billions tackling pollution Major Chinese cities afflicted by smog and dirty water are set to benefit from a huge air pollution control program, which will bring trillions of yuan to already fast developing environment industries. |
Chemistry World
August 21, 2013
Phillip Broadwith |
Two way traffic for Chinese drug licensing Chinese companies have trailed behind their Western counterparts in developing innovative new drugs. Very few of those inventions have been considered useful enough to be licensed by western companies. However, that appears to be changing. |
Chemistry World
August 19, 2013
Hepeng Jia |
Chinese drug watchdog set for major reforms China's slow drug approval process has been a cause for complaint for both Chinese subsidiaries of multinational pharmaceuticals and domestic drug developers. |
Pharmaceutical Executive
August 1, 2013
William Looney |
Breaching the Great Wall With a revision of China's basic drug approval law now underway, a multinational team of experts is proposing major changes to make the country a world class player in innovation. |
| <Older 601-610 Newer> Return to current articles. |
